Eliana Lorenti, Sofía Capasso, Gabriel Castresana, Melina Lunardelli, Fabiana Moredo, Patricia Escobar-Páramo, Julia I Diaz, Gabriela Giacoboni, Julio A Benavides
{"title":"Occurrence and characterization of ESBL- and AmpC-producing Escherichia coli in the common tern (Sterna hirundo) and surface water of Bahía Samborombón, Argentina.","authors":"Eliana Lorenti, Sofía Capasso, Gabriel Castresana, Melina Lunardelli, Fabiana Moredo, Patricia Escobar-Páramo, Julia I Diaz, Gabriela Giacoboni, Julio A Benavides","doi":"10.1016/j.jgar.2026.11.004","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.11.004","url":null,"abstract":"<p><strong>Objectives: </strong>This study determined the occurrence and genomic background of ESBL- and AmpC-E. coli in common terns (Sterna hirundo) and surrounding surface water during the non-breeding season in Bahía Samborombón, Argentina, a wetland under strong anthropogenic influence.</p><p><strong>Methods: </strong>Two hundred common tern faecal samples and 36 surface water samples were analysed. Antimicrobial resistance phenotypes were determined, and whole-genome sequencing was performed to characterise resistance genes, sequence types (STs), and virulence-associated factors.</p><p><strong>Results: </strong>One ESBL-E. coli isolate from common tern faeces, 12 ESBL- and four AmpC-E. coli from surface water were obtained. The predominant ESBL gene was bla<sub>CTX-M-15</sub>, followed by bla<sub>CTX-M-14</sub> and bla<sub>CTX-M-2</sub>, whereas AmpC production was associated with blaC<sub>MY-2</sub> and bla<sub>CMY-132</sub>. Eleven STs were identified, including ST164 from the common tern and the pandemic lineage ST38 from water samples. Closely related ST354, ST738, and ST13823 isolates were detected across different sampling periods and sites. Virulence factors associated with ExPEC/APEC and IPEC/aEPEC pathotypes were identified in six and four isolates, respectively.</p><p><strong>Conclusion: </strong>This is the first report of ESBL-E. coli in common terns in Latin America and reveals surface water contamination by multiple recurrent STs, suggesting anthropogenic drivers of antimicrobial resistance in this wetland ecosystem.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pathogenesis and genomic architecture of azole-resistant Candida albicans isolated from the male genitourinary tract.","authors":"Yu Shen, Liqun Gu, Suna Jiang, Yi Zhou, Wenxia Gao, Jinrong Feng","doi":"10.1016/j.jgar.2026.11.006","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.11.006","url":null,"abstract":"<p><strong>Background: </strong>Recurrent genitourinary candidiasis caused by azole-resistant Candida albicans presents a significant therapeutic challenge. However, the pathogenesis and genomic architecture of these resistant strains in the male reproductive tract mucosal microenvironment remain poorly understood.</p><p><strong>Methods: </strong>Two C. albicans strains isolated from the glans penis (G1) and urethra (N1) of a single male patient with itraconazole treatment failure were analyzed. Antifungal susceptibility was evaluated using a commercial broth microdilution kit for MIC determination, supplemented by spotting assays. Genomic variations were profiled via WGS and cross-referenced with the FungAMR database. Ergosterol synthesis was assessed by spectrophotometry and qPCR, and in vivo virulence was evaluated using a Galleria mellonella infection model.</p><p><strong>Results: </strong>Susceptibility testing revealed that both isolates exhibited high-level cross-resistance to azoles while remaining susceptible to amphotericin B. WGS demonstrated deep clonal identity (>99.99%) and identified shared non-synonymous mutations in 67 resistance-associated genes. Azole resistance was associated with mutations in the ergosterol pathway, alongside a significant burden of copy number variations (CNVs). Spatial phenotypic heterogeneity was observed: compared to the glans isolate (G1), the urethral isolate (N1) showed a 42.5% reduction in ergosterol synthesis and significant attenuation of in vivo virulence, correlating with marked transcriptional downregulation of host-adherence factors.</p><p><strong>Conclusion: </strong>This single-patient study found azole-resistant C. albicans from the male genital tract with ERG pathway mutations and structural genomic variations, alongside a virulence trade-off. These findings raise the possibility that prolonged empirical azole monotherapy may be inadequate and underscore the importance of following clinical guidelines and considering susceptibility results.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana Luísa Fadini Saleme Abreu, Carolina Magri Ferraz, Marita Vedovelli Cardozo, João Pedro Rueda Furlan, Gabriel Augusto Marques Rossi
{"title":"Co-occurrence of mecA and cfr in Staphylococcus saprophyticus isolated from bulk tank milk.","authors":"Ana Luísa Fadini Saleme Abreu, Carolina Magri Ferraz, Marita Vedovelli Cardozo, João Pedro Rueda Furlan, Gabriel Augusto Marques Rossi","doi":"10.1016/j.jgar.2026.11.003","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.11.003","url":null,"abstract":"","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Epeng Lee, Dalene Lesen, Darren Dean Tay, Atna Permana, Nurzafirah Mazlan, Tze Young Thung
{"title":"Characterization of a lytic phage Vp16M (genus Maculvirus) and its endolysin against Vibrio parahaemolyticus.","authors":"Epeng Lee, Dalene Lesen, Darren Dean Tay, Atna Permana, Nurzafirah Mazlan, Tze Young Thung","doi":"10.1016/j.jgar.2026.11.001","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.11.001","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to isolate and characterize a lytic phage targeting Vibrio parahaemolyticus and evaluate its endolysin for potential application as antimicrobial agents.</p><p><strong>Methods: </strong>A phage was isolated from seawater using V. parahaemolyticus ATCC 17802 as host. Morphological, physiological, and genomic analyses were performed, followed by cloning and expression of the endolysin gene. The lytic activity and stability of the recombinant endolysin were assessed under different conditions. Finally, antimicrobial efficacy of phage and endolysin in combination with citric acid were tested on shrimp paste.</p><p><strong>Results: </strong>The phage Vp16M exhibited a short latent period, high burst size, and broad stability across temperature and pH ranges, with no virulence or resistance genes detected. Its endolysin Lys16M showed strong lytic activity, stability, and the Lys16M-citric acid combination resulted in a 2.4-log reduction of bacterial counts.</p><p><strong>Conclusion: </strong>Phage Vp16M and endolysin Lys16M demonstrate promising antimicrobial properties and safety profiles, supporting their potential as biocontrol agents against V. parahaemolyticus.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Niloofar Rezaie, Masoumeh Beig, Mahshid Kalantar-Neyestanaki, Nima Mohammadzadeh, Negin Kiani, Mohammad Sholeh, Farzad Badmasti
{"title":"Global Genomic Analysis of Antimicrobial Resistance in Streptococcus pyogenes.","authors":"Niloofar Rezaie, Masoumeh Beig, Mahshid Kalantar-Neyestanaki, Nima Mohammadzadeh, Negin Kiani, Mohammad Sholeh, Farzad Badmasti","doi":"10.1016/j.jgar.2026.10.007","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.10.007","url":null,"abstract":"<p><strong>Background: </strong>Streptococcus pyogenes (Group A Streptococcus, GAS) is a major global pathogen. While macrolide resistance has been studied, large-scale analyses of overall antimicrobial resistance (AMR) in GAS across geographic datasets remain limited. This study aimed to comprehensively investigate AMR in GAS over more than a century.</p><p><strong>Methods: </strong>A total of 47,689 high-quality S. pyogenes genomes from 59 countries, collected between 1900 and 2025 (predominantly post-1990), underwent quality control. Multilocus sequence typing and in silico prediction of AMR determinants using AMRFinderPlus v4.2.5 were performed. Temporal trends were analyzed via quasibinomial regression. Phenotypic susceptibility data from 310 isolates were interpreted using CLSI 2023 breakpoints.</p><p><strong>Results: </strong>GAS showed high genomic conservation (mean genome size, ∼1.81 Mb; ∼1,705 coding sequences). The non-macrolide resistome was dominated by tetracycline and aminoglycoside-associated genes, with tet(M) being the most prevalent (20.96%), followed by aph(3')-IIIa (8.50%), sat4 (8.30%), and ant(6)-Ia (7.69%). Overtime, the prevalence of sat4, aph(3')-IIIa, ant(6)-Ia, and tet(M) increased significantly, whereas that of tet(L), tet(O), and pbp2x_P601L declined (P < 0.05). Reduced susceptibility to selected β-lactams (cefuroxime, imipenem, meropenem) was sporadic (3-10%), primarily linked to pbp2x_P601L, whereas penicillin retained near-universal activity (99.7% susceptibility). Typical β-lactamase genes were rare and geographically restricted. Phenotypic resistance was detected for tetracycline (6%) and trimethoprim-sulfamethoxazole (4%), with 13% showing intermediate susceptibility to trimethoprim-sulfamethoxazole.</p><p><strong>Conclusions: </strong>S. pyogenes remains highly susceptible to penicillin and other β-lactams. Resistance is mainly associated with tetracycline and aminoglycoside genes, which show dynamic changes over time due to ongoing selection pressures.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149342377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jia Haw Wong, Jia Jie Woon, Sasheela Sri La Sri Ponnampalavanar, Hidenori Yamashiro, Dai Miyagawa, Motoyasu Onishi, Miki Takemura, Yoshinori Yamano, Cindy Shuan Ju Teh
{"title":"In Vitro Activity of Cefiderocol against Carbapenem-Resistant Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii and the Cefiderocol Resistance Mechanisms.","authors":"Jia Haw Wong, Jia Jie Woon, Sasheela Sri La Sri Ponnampalavanar, Hidenori Yamashiro, Dai Miyagawa, Motoyasu Onishi, Miki Takemura, Yoshinori Yamano, Cindy Shuan Ju Teh","doi":"10.1016/j.jgar.2026.10.011","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.10.011","url":null,"abstract":"<p><strong>Background: </strong>Extensively drug-resistant and pandrug-resistant Gram-negative bacteria, including Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, pose a major threat due to limited treatment options and high mortality. Rising prevalence of carbapenem resistance has further complicated therapy, necessitating novel antimicrobial agents. Cefiderocol, a siderophore-conjugated cephalosporin, offers a promising therapeutic option against these multidrug-resistant pathogens.</p><p><strong>Objectives: </strong>To assess the in vitro activity of cefiderocol and key comparators against carbapenem-resistant Gram-negative bacteria from a Malaysian hospital.</p><p><strong>Methods: </strong>A total of 448 non-duplicate carbapenem-resistant bacterial strains collected from the University Malaya Medical Centre diagnostic laboratory from year 2018-2021 were included. Broth microdilution was used for susceptibility testing of cefiderocol and other agents relevant to the respective carbapenem-resistant organisms (CROs), in accordance with CLSI guidelines. Susceptibility was interpreted using CLSI breakpoints, with FDA breakpoints applied for tigecycline. Genotypic detection of antimicrobial resistance-associated genes was performed via polymerase chain reaction. Whole genome sequencing was performed on cefiderocol-resistant isolates for genetic characterisation.</p><p><strong>Results: </strong>Cefiderocol demonstrated the highest susceptibility rate for the tested CROs when compared to other antimicrobial agents. More than 90% of the carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Acinetobacter baumannii isolates were susceptible to cefiderocol, whereas 81.2% of carbapenem-resistant Pseudomonas aeruginosa isolates were susceptible. Among a total of 22 cefiderocol-resistant isolates, 17 isolates produced NDM-1 and 11 isolates produced PER or VEB ESBL.</p><p><strong>Conclusions: </strong>Cefiderocol remains an effective treatment option for patients infected with CROs. Ongoing surveillance and antibiotic stewardship are essential to monitor the emergence of resistance and preserve the effectiveness of cefiderocol against multidrug-resistant pathogens.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149334092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prior ceftriaxone susceptibility and current nonsusceptibility in paired urinary isolates over time: a retrospective longitudinal cohort study.","authors":"Yanan Liu, Wei Yu, Huarong Wang","doi":"10.1016/j.jgar.2026.10.010","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.10.010","url":null,"abstract":"<p><strong>Objective: </strong>To quantify how the association between prior ceftriaxone susceptibility and current nonsusceptibility varies across culture intervals and whether it differs by species concordance or recorded antibiotic exposure between cultures.</p><p><strong>Methods: </strong>We conducted a retrospective longitudinal cohort study using the 1999-2024 Antibiotic Resistance Microbiology Dataset. Emergency department-associated urine cultures yielding Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis with direct ceftriaxone susceptibility results were paired with the most recent eligible prior culture obtained more than 14 days earlier. Logistic generalised estimating equations adjusted for age group and anonymised gender code estimated marginal standardised probabilities, risk differences, and risk ratios across eight intervals.</p><p><strong>Results: </strong>The analysis included 4,547 culture pairs from 2,993 patients; 654 current isolates (14.4%) were nonsusceptible. At 15-30 days, the adjusted probability of current nonsusceptibility was 92.3% after a prior nonsusceptible result versus 4.7% after a prior susceptible result; at 31-60 days, probabilities were 88.3% versus 3.8%. Adjusted risk differences were 87.6 and 84.4 percentage points, respectively. Beyond 1095 days, probabilities were 22.1% versus 7.3% (risk difference, 14.8 percentage points; risk ratio, 3.01). The susceptibility-by-interval interaction was significant (P < 0.001). The association was stronger in same-species pairs and differed by recorded antibiotic exposure between cultures (both interaction P < 0.001).</p><p><strong>Conclusions: </strong>Prior ceftriaxone susceptibility provided time-dependent, patient-specific information about current nonsusceptibility. Recent prior nonsusceptibility, particularly with species concordance, was associated with a high probability of current nonsusceptibility, although the association attenuated over time.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149334093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sho Saito, Aki Sakurai, Yasufumi Matsumura, Ryota Hase, Hideaki Kato, Kohei Uemura, Naoya Itoh, Takehiro Hashimoto, Momoko Mawatari, Jiefu Yu, Kayoko Hayakawa, Masahiro Suzuki, Yusuke Asai, David van Duin, Norio Ohmagari, Yohei Doi
{"title":"Clinical Outcomes of Carbapenem-Resistant versus Carbapenem-Susceptible Pseudomonas aeruginosa Infections in Japan: A Multicenter Matched Case-Control Study by the Multi-Drug Resistant Organisms Clinical Research Network (MDRnet).","authors":"Sho Saito, Aki Sakurai, Yasufumi Matsumura, Ryota Hase, Hideaki Kato, Kohei Uemura, Naoya Itoh, Takehiro Hashimoto, Momoko Mawatari, Jiefu Yu, Kayoko Hayakawa, Masahiro Suzuki, Yusuke Asai, David van Duin, Norio Ohmagari, Yohei Doi","doi":"10.1016/j.jgar.2026.10.009","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.10.009","url":null,"abstract":"<p><strong>Objectives: </strong>Carbapenem-resistant Pseudomonas aeruginosa (CRPA) represents a major global public health concern. As data on its prognostic impact in Japan are limited, we evaluated the impact of carbapenem resistance on clinical outcomes in patients with P. aeruginosa infections.</p><p><strong>Methods: </strong>We conducted a matched case-control study using data from the Multi-Drug Resistant Organisms Clinical Research Network. Patients with CRPA infection were matched 1:1 to patients with carbapenem-susceptible P. aeruginosa (CSPA) infection at eight tertiary care hospitals in Japan. Appropriate therapy was defined as therapy with agents to which the index isolates were susceptible.</p><p><strong>Results: </strong>We included 278 patients (139 per group). Appropriate empiric therapy was administered to 33.3% of CRPA and 89.1% of CSPA patients, and appropriate definitive therapy to 61.1% and 91.1%, respectively. Thirty-day mortality did not differ significantly (17.8% vs. 10.1%, p = 0.080), whereas in-hospital mortality was significantly higher in the CRPA group (29.7% vs. 15.8%, p = 0.007). Among survivors, post-culture hospital stay was longer in the CRPA group (median, 35 vs. 25 days; p = 0.009). After adjustment for comorbidity and illness severity, CRPA was associated with higher in-hospital mortality (OR, 4.75; 95% CI, 1.54-14.67) and longer hospital stay (estimate, 1.42; 95% CI, 1.13-1.78); however, these associations were attenuated after further adjustment for appropriate empiric therapy.</p><p><strong>Conclusions: </strong>CRPA was associated with higher in-hospital mortality and longer hospital stay, possibly reflecting, in part, differences in empiric therapy. No significant association with 30-day mortality was observed, although statistical power was limited.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149334091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Toru Higuchi, Meiji Soe Aung, Noriko Urushibara, Mitsuyo Kawaguchiya, Nobuhide Ohashi, Satoshi Suzuki, Mina Hirose, Masahiko Ito, Kazuki Yamada, Kousuke Tada, Takeshi Tsugawa, Nobumichi Kobayashi
{"title":"Molecular epidemiological characteristics and recent trend of methicillin-resistant Staphylococcus aureus (MRSA) in northern Japan: the shift of major clonal group to CC1-IV (ST1/ST2725, spa-t1784) and occurrence of various novel MRSA clones.","authors":"Toru Higuchi, Meiji Soe Aung, Noriko Urushibara, Mitsuyo Kawaguchiya, Nobuhide Ohashi, Satoshi Suzuki, Mina Hirose, Masahiko Ito, Kazuki Yamada, Kousuke Tada, Takeshi Tsugawa, Nobumichi Kobayashi","doi":"10.1016/j.jgar.2026.10.012","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.10.012","url":null,"abstract":"<p><strong>Objectives: </strong>Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of infectious diseases. We analyzed the recent trends in molecular epidemiology of MRSA in northern Japan.</p><p><strong>Methods: </strong>MRSA isolates from all types of clinical specimens were genetically classified by MLST and typing schemes of SCCmec, spa, coa, and agr. Antimicrobial susceptibility was measured by broth microdilution test, and resistance/virulence determinants were detected by multiplex/uniplex PCR, and sequencing as required.</p><p><strong>Results: </strong>A total of 321 MRSA isolates were collected during the 6-month period in 2025, and differentiated into three major clonal groups, clonal complex 1-SCCmec IV (CC1-IV)-coa-VIIa (62%), CC5-II-coa-IIa (27%), and CC8-IV-coa-IIIa (6%). The proportion of CC1-IV in 2025 increased significantly compared with that in 2011-2014 (<10%), associated with the decrease in CC5-II, while CC8-IV showed persistently low prevalence. CC1 isolates comprised a predominant ST1 and minor ST2725 and ST2764, with dominant spa-type t1784. Most CC5 MRSA consisted of ST5 (64%) and ST764 (35%), with half of ST764 isolates carrying arginine catabolic mobile element (ACME) type II'. Panton-Valentine leukocidine (PVL) genes were detected in ST8-IVa/spa-t008 with ACME-I (USA300 clone), ST22-IV with tst-1 (ST22-PT clone), ST1232 (CC398)-V, and ST10821 (ST8-single locus variant)-IVa. PVL-negative ST8 with SCCmec-IVl (CAMRSA/J clone, n=7) was found to harbor novel enterotoxin gene se01/sel30. As rare clones in Japan, ST5-IV (n=2) and ST5-VI (n=1) were identified in this study.</p><p><strong>Conclusions: </strong>This study revealed the recent clonal shift of major MRSA in northern Japan, along with the occurrence of presumptive emerging clones.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical impact of third-generation cephalosporin resistance in hospitalized patients with upper urinary tract infections: a retrospective propensity score-matched study.","authors":"Alassane Sarr, Moustapha Diop, Samba Tounkara, Huyen Trang Nghiem, Hassan Choker, Hamade Zonon, Hiba Diab, Sirine Smaoui, Maxence Rouyer, Matta Antoun Matta, Sylvain Diamantis","doi":"10.1016/j.jgar.2026.10.008","DOIUrl":"https://doi.org/10.1016/j.jgar.2026.10.008","url":null,"abstract":"<p><strong>Background: </strong>Third-generation cephalosporins are commonly used as empirical therapy for hospitalized patients with upper urinary tract infections. However, the increasing prevalence of 3GC-resistant Enterobacterales, mainly driven by extended-spectrum β-lactamase production, has raised concerns regarding inadequate empirical treatment and increased carbapenem use. The independent impact of 3GC resistance on outcomes in non-severe UUTIs remains unclear. We assessed whether 3GC resistance was associated with relapse, clinical failure, or mortality among hospitalized patients with UUTIs initially treated with 3GCs.</p><p><strong>Methods: </strong>We conducted a retrospective observational study including adults hospitalized for Enterobacterales UUTIs between January 2022 and December 2024 at a French tertiary hospital. Patients with septic shock or requiring urgent urinary drainage were excluded. Patients with 3GC-R infections were compared with those infected by susceptible strains. All matched patients received empirical 3GC therapy. Propensity score matching (1:1) was performed using demographic and clinical variables. The primary outcome was relapse within one month after treatment. Secondary outcomes were clinical failure and in-hospital mortality.</p><p><strong>Results: </strong>Among 582 UUTIs, 9.1% involved 3GC-R Enterobacterales; 69.8% resistant isolates were ESBL producers. After propensity score matching, 44 pairs were analyzed. Although empirical therapy was initially inactive in most resistant infections, treatment was adapted within 48-72 hours. One-month relapse rates were identical in both groups (9.1% vs 9.1%; p=1.00). Clinical failure and in-hospital mortality were also similar.</p><p><strong>Conclusion: </strong>In hospitalized patients with non-severe UUTIs, 3GC resistance was not associated with worse clinical outcomes after early therapeutic adaptation. Empirical carbapenem escalation should be guided by severity and individual risk factors rather than resistance risk alone.</p>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149321933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}